Stephen L. Sabba

Director, LIGAND PHARMACEUTICALS INC.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 16, 2026Sold 2,145 shares at $254.00 of LIGAND PHARMACEUTICALS INC²
Jun 16, 2026Exercised options 2,145 shares at $66.13 of LIGAND PHARMACEUTICALS INC²
Jun 5, 2026Granted 836 shares of LIGAND PHARMACEUTICALS INC³
Mar 23, 2026Sold 1,000 shares at $207.87 of LIGAND PHARMACEUTICALS INC⁴
Mar 3, 2026Sold 2,034 shares at $201.50 of LIGAND PHARMACEUTICALS INC⁵
Mar 3, 2026Exercised options 2,034 shares at $69.51 of LIGAND PHARMACEUTICALS INC⁵
Jun 6, 2025Granted 1,209 shares of LIGAND PHARMACEUTICALS INC⁶
Apr 1, 2025Exercised options 2,406 shares at $52.30 of LIGAND PHARMACEUTICALS INC⁷
Jun 14, 2024Granted 1,252 shares of LIGAND PHARMACEUTICALS INC⁸
Mar 5, 2024Sold 1,893 shares at $74.30 of LIGAND PHARMACEUTICALS INC⁹
Mar 5, 2024Exercised options 2,893 shares of LIGAND PHARMACEUTICALS INC⁹
Jun 9, 2023Granted 1,142 shares of LIGAND PHARMACEUTICALS INC¹⁰
May 10, 2023Sold 6,408 shares at $77.13 of LIGAND PHARMACEUTICALS INC¹¹
May 10, 2023Exercised options 6,408 shares of LIGAND PHARMACEUTICALS INC¹¹
Jun 10, 2022Granted 1,004 shares of LIGAND PHARMACEUTICALS INC¹²

The numbers on this page point here. Each one links to the record it came from.